It is a business outsourcing private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | ActiveOrris Pharmaceuticals Private Limited, a active private limited company, was established on 01 June 2020 in Hyderabad, Telangana, India. Engaging in accounting and financial analysis within the hospital and medical care sector, it holds CIN: U24110TG2020PTC140528. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Employing 46 professional, Its leadership includes Srinivasa Rao Pappala (Director), Gollapudi Srinivasa Rao (Managing Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 49.H.No.12-13-779, 1 St No 1 Lane No 2 Kimti Colony, Siddartha Nagar, Tarnaka, Hyderabad, Telangana, 500017.
U24110TG2020PTC140528
140528
01 June 2020
₹1.00 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Orris Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Rao Pappala | Director | 01 Jun 2020 | Current |
| Gollapudi Srinivasa Rao | Managing Director | 01 Jun 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orris Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.48% increase. The company also saw a substantial improvement in profitability, with a 35.6% increase in profit. The company's net worth Soared by an impressive increase of 71.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Orris Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Orris Pharmaceuticals has a workforce of 46 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Orris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orris Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Orris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Orris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Srinivasa Rao Pappala was appointed as a Director was appointed as a Director on 01 Jun 2020 & has been associated with this company since 5 years 6 months . was completed.
Gollapudi Srinivasa Rao was appointed as a Managing Director was appointed as a Managing Director on 01 Jun 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
Orris Pharmaceuticals Private Limited was registered on 01 Jun 2020 with Roc Hyderabad & aged 5 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Orris Pharmaceuticals Private Limited is U24110TG2020PTC140528.
Orris Pharmaceuticals Private Limited is headquartered at Plot No 49.H.No.12-13-779, 1 St No 1 Lane No 2 Kimti Colony, Siddartha Nagar, Tarnaka, Hyderabad, Telangana, 500017.
Orris Pharmaceuticals Private Limited was incorporated on 01 June 2020.
The current directors of Orris Pharmaceuticals Private Limited are
The primary industry of Orris Pharmaceuticals Private Limited is Hospital And Medical Care.
Orris Pharmaceuticals Private Limited is unlisted.
The authorized capital of Orris Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX